Lycia Therapeutics, Inc. (LYCA): who owns it and who trades it
As of Nov 4, 2026, LYCA insiders reported 12 purchases worth $38.5M in the last 12 months. The largest buyer was Venrock Healthcare Capital Partners III, L.P. (10% owner), with $38.5M.
Latest filing Nov 4, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Insider trades
In the last 12 months, LYCA insiders reported $38.5M of open-market purchases and $0 of sales.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | Venrock Healthcare Capital Partners III, L.P. +8 | 10% owner | Purchase | 8,305 | $26.95 | $224K | Form 4 |
| Oct 30, 2026 | Venrock Healthcare Capital Partners III, L.P. +8 | 10% owner | Purchase | 8,804 | $26.27 | $231K | Form 4 |
| Oct 30, 2026 | Venrock Healthcare Capital Partners III, L.P. +8 | 10% owner | Purchase | 200 | $26.86 | $5.4K | Form 4 |
| Oct 29, 2026 | Venrock Healthcare Capital Partners III, L.P. +8 | 10% owner | Purchase | 1,000 | $26.33 | $26.3K | Form 4 |
| Oct 28, 2026 | Venrock Healthcare Capital Partners III, L.P. +8 | 10% owner | Purchase | 10,570 | $25.23 | $267K | Form 4 |
| Oct 28, 2026 | Venrock Healthcare Capital Partners III, L.P. +8 | 10% owner | Purchase | 4,430 | $25.97 | $115K | Form 4 |
| Oct 27, 2026 | Venrock Healthcare Capital Partners III, L.P. +8 | 10% owner | Purchase | 8,729 | $25.84 | $226K | Form 4 |
| Oct 27, 2026 | Venrock Healthcare Capital Partners III, L.P. +8 | 10% owner | Purchase | 31,067 | $26.84 | $834K | Form 4 |
| Oct 26, 2026 | Venrock Healthcare Capital Partners III, L.P. +8 | 10% owner | Purchase | 1.94M | $18.00 | $35M | Form 4 |
| Oct 26, 2026 | Venrock Healthcare Capital Partners III, L.P. +8 | 10% owner | Purchase | 8,261 | $26.97 | $223K | Form 4 |
| Oct 23, 2026 | Venrock Healthcare Capital Partners III, L.P. +8 | 10% owner | Purchase | 24,560 | $25.68 | $631K | Form 4 |
| Oct 23, 2026 | Venrock Healthcare Capital Partners III, L.P. +8 | 10% owner | Purchase | 28,379 | $26.11 | $741K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. | 10% owner | $38.5M | – | Nov 2, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
LYCA short interest
304,185 LYCA shares are sold short.
As of Oct 30, 2026, 304,185 LYCA shares were sold short. At the average daily volume of 400,880 shares, buying them all back would take about 1.0 trading days (days to cover).
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 304,185 | – | – | 400,880 | 1.0 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Lycia Therapeutics company events
Lycia Therapeutics filed 1 report on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Oct 26, 2026.
- Oct 26, 2026RulesChanged its bylaws or articles. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named LYCA in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Oct 30, 2026 | Venrock Healthcare Capital Partners III, L.P. | 13G | 11.9% |
| Oct 30, 2026 | Venrock Healthcare Capital Partners III, L.P. | 13G | 11.9% |
Questions about Lycia Therapeutics, Inc. (LYCA) stock
Are LYCA insiders buying or selling?
In the last 12 months, LYCA insiders reported 12 open-market purchases worth $38.5M and no sales. The latest trade was on Nov 2, 2026. See every trade.
What is the short interest in LYCA?
As of Oct 30, 2026, 304,185 LYCA shares were sold short. At the average daily volume of 400,880 shares, buying them all back would take about 1.0 trading days (days to cover). See the history.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.